Skip to main content
Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
4.220
-0.190 (-4.31%)
At close: Apr 28, 2026, 4:00 PM EDT
4.200
-0.020 (-0.47%)
After-hours: Apr 28, 2026, 4:29 PM EDT

Aclaris Therapeutics Revenue

In the year 2025, Aclaris Therapeutics had annual revenue of $7.83M, down -58.19%. Aclaris Therapeutics had revenue of $1.30M in the quarter ending December 31, 2025, a decrease of -85.94%.

Revenue (ttm)
$7.83M
Revenue Growth
-58.19%
P/S Ratio
75.48
Revenue / Employee
$107,205
Employees
73
Market Cap
586.56M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20257.83M-10.89M-58.19%
Dec 31, 202418.72M-12.53M-40.09%
Dec 31, 202331.25M1.50M5.03%
Dec 31, 202229.75M22.99M340.05%
Dec 31, 20216.76M279.00K4.30%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CorMedix 311.71M
Rigel Pharmaceuticals 294.28M
Zevra Therapeutics 106.47M
Prothena Corporation 9.68M
Adlai Nortye 5.00M
Ocugen 4.41M
Absci 2.80M
Shattuck Labs 1.00M
Revenue Rankings

ACRS News

More News